Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Cancer Germline Antigen Specific CTL As Immunotherapy for Neuroblastoma

Dan Li, MD, Fanqi Bai, MD, Kumaran Sundaram, PhD, Deepa K. Krishnadas, PhD, Kenneth Lucas, MD

Blood (2015) 126 (23): 4300.

https://doi.org/10.1182/blood.V126.23.4300.4300

Published: 2015

Journal Articles

CT Antigen-Specific Immune Response From DAC/DC Vaccine Correlates With Clinical Outcome In Patients With Relapsed Neuroblastoma

Deepa Kolaseri Krishnadas, PhD, Fanqi Bai, MD, Kenneth Lucas

Blood (2013) 122 (21): 2023.

https://doi.org/10.1182/blood.V122.21.2023.2023

Published: 2013

Journal Articles

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

John Powers, B.S., Eric Padron, MD, Jason Dubovsky, Ph.D, Emmanuel Berchmans, B.S., Tyler Farnum, Fanqi Bai, MD, Eva Sahakian, Ph.D, Jamil Ahmed, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Douglas G McNeel, MD, Sophie Dessureault, MD, Scott Antonia, MD, Eduardo M. Sotomayor, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD, PhD

Blood (2011) 118 (21): 1725.

https://doi.org/10.1182/blood.V118.21.1725.1725

Published: 2011

Journal Articles

Phase 2 Multicenter Trial of Rabbit Anti-Thymocyte Serotherapy In Myelodysplastic Syndrome: Rate of Hematological Improvement Associated with Pre-Treatment Disease Duration

P.K. Epling-Burnette, PharmD, PhD, Rami S. Komrokji, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Mikkael A. Sekeres, MD, MS, Ronald Paquette, MD, Sheng Wei, MD, Jeffrey S Painter, BS, Fanqi Bai, MD, William J Fulp, Jennifer Paleveda-Pena, Dung-Tsa Chen, PhD, Alan F. List, MD

Blood (2010) 116 (21): 602.

https://doi.org/10.1182/blood.V116.21.602.602

Published: 2010

Journal Articles

Autoproliferation Contributes to Clonal Expansion and Changes In Cellular Topography In T Cell Large Granular Lymphocyte (LGL) Leukemia

JianXiang Zou, MD, Jeffrey S Painter, BS, Fanqi Bai, MD, Lubomir Sokol, MD, PhD, Thomas P. Loughran, Jr., MD, P.K. Epling-Burnette, PharmD, PhD

Blood (2010) 116 (21): 1373.

https://doi.org/10.1182/blood.V116.21.1373.1373

Published: 2010

Journal Articles

Altered Collagen Production by Dysfunctional Mesenchymal Stem Cells Is Linked to T Cell Large Granular Lymphocyte Leukemia Pathophysiology.

Adam W. Mailloux, PhD, Fanqi Bai, MD, Ling Zhang, MD, Eric Padron, MD, Lili Yang, PhD, Cody Wei, Amber Schmidt, Lubomir Sokol, MD, PhD, Dung-Tsa Chen, PhD, Thomas P. Loughran, Jr., MD, Alan F. List, MD, P. K. Epling-Burnette, PharmD, PhD

Blood (2010) 116 (21): 2595.

https://doi.org/10.1182/blood.V116.21.2595.2595

Published: 2010

Journal Articles

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

JianXiang Zou, MD, Dana E Rollison, PhD, David Boulware, MS, Elaine M. Sloand, MD, Loretta Pfannes, BS, Fanqi Bai, MD, Jeffrey S. Painter, BS, Sheng Wei, MD, Denise Cosgrove, RN, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2008) 112 (11): 3647.

https://doi.org/10.1182/blood.V112.11.3647.3647

Published: 2008

Journal Articles

First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.

P.K. Epling-Burnette, PhD, Lubomir Sokol, MD, Lynn Moscinski, MD, Magda Elkabani, MD, Fanqi Bai, MD, Michelle Blaskovich, BS, JianXiang Zou, MD, Jeffrey S. Painter, BS, Said Sebti, PhD, Thomas P. Loughran, MD

Blood (2007) 110 (11): 3132.

https://doi.org/10.1182/blood.V110.11.3132.3132

Published: 2007

Journal Articles

Constitutive Activation of Ras and Mitogen-Activated Protein Kinase (MAPK/ERK) in LGL Leukemia Unrelated to Activating Mutations in N and KRas Genes.

Jeffrey S. Painter, BS, Angela Costellanos, Fanqi Bai, MD, Sheng Wei, MD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2007) 110 (11): 3180.

https://doi.org/10.1182/blood.V110.11.3180.3180

Published: 2007

Journal Articles

Th2 Polarization Induced by the Farnesyltransferase Inhibitor Tipifarnib (Zarnestra®, R115777) through Suppression of T-bet.

Fanqi Bai, MD, J.-X. Zou, MD, Sheng Wei, MD, Jeffrey S. Painter, BS, Michelle Blaskovich, Bs, Said Sebti, PhD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2007) 110 (11): 1331.

https://doi.org/10.1182/blood.V110.11.1331.1331

Published: 2007

Journal Articles

Aberrant NK Receptor Signaling Associated with Large Granular Lymphoycte Leukemia and Primary Pulmonary Hypertension.

P.K. Epling-Burnette, PhD, Xianhong Chen, Junmin Zhou, Fanqi Bai, MD, Sokol Lubomir, MD, Edna Ku, MD, Jeffrey S. Painter, BS, Zou JianXiang, MD, Todd D. Edwards, MD, Djeu Y. Julie, PhD, Moscinski C. Lynn, MD, Thomas P. Loughran, MD, Sheng Wei, MD

Blood (2007) 110 (11): 4704.

https://doi.org/10.1182/blood.V110.11.4704.4704

Published: 2007

Journal Articles

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Rollison Dana, PhD, JianXiang Zou, MD, Edna Ku, MD, Bin Zhong, BS, Sheng Wei, MD, Julie Y. Djeu, PhD, Alan F. List, MD

Blood (2006) 108 (11): 2651.

https://doi.org/10.1182/blood.V108.11.2651.2651

Published: 2006

Journal Articles

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Edna Ku, MD, PhD, JianXiang Zou, MD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 2659.

https://doi.org/10.1182/blood.V108.11.2659.2659

Published: 2006

Journal Articles

Lenalidomide (CC5013, Revlimid®) Alters a T Cell Homeostatic Check-Point in Patients with Myelodysplastic Syndrome (MDS).

JianXiang Zou, MD, Edna Ku, MD, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 851.

https://doi.org/10.1182/blood.V108.11.851.851

Published: 2006

Journal Articles

Complex Immunosuppressive Action of Farnesyltransferase Inhibitor (FTI) R115777 (Tipifarnib, Zarnestra®) with Induction of Apoptosis in T Cells from Patients with Large Granular Lymphocyte (LGL) Leukemia.

Fanqi Bai, MD, JianXiang Zou, MD, Jun Yang, MD, Edna Ku, MD,PhD, Sheng Wei, MD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 4960.

https://doi.org/10.1182/blood.V108.11.4960.4960

Published: 2006

Journal Articles

T Large Granular Lymphocyte (LGL) Leukemia Characterized by Expansion of Terminal CD3+/CD8+/CD62L−/CD45RA+ Effector Memory T Cells.

JianXiang Zou, MD, Jeffrey S. Painter, BS, Fanqi Bai, MD, Thomas P. Loughran, MD, P.K. Epling-Burnette, PhD

Blood (2006) 108 (11): 4962.

https://doi.org/10.1182/blood.V108.11.4962.4962

Published: 2006

Journal Articles

Natural Killer Cells with NKDG2D Cytotoxicity but NKp30-Dull Phenotype Predominate in Myelodysplastic Syndrome (MDS).

Fanqi Bai, MD, Jeffrey S. Painter, Cantor Alan, PhD, Zou JianXiang, MD, Sheng Wei, MD, Julie Y. Djeu, PhD, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2005) 106 (11): 3436.

https://doi.org/10.1182/blood.V106.11.3436.3436

Published: 2005

Journal Articles

Lenalidomide Effects on NK Function in Patients with Myelodysplastic Syndrome (MDS).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, Julie Y. Djeu, PhD, Alan F. List, MD

Blood (2005) 106 (11): 3437.

https://doi.org/10.1182/blood.V106.11.3437.3437

Published: 2005

Journal Articles

In Addition to Immune Suppression, There Is Defective Maturation of CD34 + Cells in Patients with Natural Killer-Lymphoproliferative Disease of Granular Lymphcoytes (NK-LDGL).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, Thomas P. Loughran, MD

Blood (2005) 106 (11): 2404.

https://doi.org/10.1182/blood.V106.11.2404.2404

Published: 2005

NARROW

Cancer Germline Antigen Specific CTL As Immunotherapy for Neuroblastoma

CT Antigen-Specific Immune Response From DAC/DC Vaccine Correlates With Clinical Outcome In Patients With Relapsed Neuroblastoma

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

Phase 2 Multicenter Trial of Rabbit Anti-Thymocyte Serotherapy In Myelodysplastic Syndrome: Rate of Hematological Improvement Associated with Pre-Treatment Disease Duration

Autoproliferation Contributes to Clonal Expansion and Changes In Cellular Topography In T Cell Large Granular Lymphocyte (LGL) Leukemia

Altered Collagen Production by Dysfunctional Mesenchymal Stem Cells Is Linked to T Cell Large Granular Lymphocyte Leukemia Pathophysiology.

Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome

First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.

Constitutive Activation of Ras and Mitogen-Activated Protein Kinase (MAPK/ERK) in LGL Leukemia Unrelated to Activating Mutations in N and KRas Genes.

Th2 Polarization Induced by the Farnesyltransferase Inhibitor Tipifarnib (Zarnestra®, R115777) through Suppression of T-bet.

Aberrant NK Receptor Signaling Associated with Large Granular Lymphoycte Leukemia and Primary Pulmonary Hypertension.

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

Lenalidomide (CC5013, Revlimid®) Promotes T Helper-1 Function Bias and Increases Responsiveness to Autologous Bone Marrow Antigens in Myelodysplastic Syndrome (MDS).

Lenalidomide (CC5013, Revlimid®) Alters a T Cell Homeostatic Check-Point in Patients with Myelodysplastic Syndrome (MDS).

Complex Immunosuppressive Action of Farnesyltransferase Inhibitor (FTI) R115777 (Tipifarnib, Zarnestra®) with Induction of Apoptosis in T Cells from Patients with Large Granular Lymphocyte (LGL) Leukemia.

T Large Granular Lymphocyte (LGL) Leukemia Characterized by Expansion of Terminal CD3+/CD8+/CD62L−/CD45RA+ Effector Memory T Cells.

Natural Killer Cells with NKDG2D Cytotoxicity but NKp30-Dull Phenotype Predominate in Myelodysplastic Syndrome (MDS).

Lenalidomide Effects on NK Function in Patients with Myelodysplastic Syndrome (MDS).

In Addition to Immune Suppression, There Is Defective Maturation of CD34 + Cells in Patients with Natural Killer-Lymphoproliferative Disease of Granular Lymphcoytes (NK-LDGL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only